In another important finding, the authors demonstrate that UBQLN2-mediated proteolysis of aggregation-prone proteins appears to take place solely via the 26S proteasome. Whereas proteasome inhibition prevents aggregate clearance, autophagy-deficient (atg5 knockout) cells are capable of clearing aggregates as efficiently as wild-type cells. These results are surprising, given that the proteasome contains a narrow (1.5 nm) entrance to its proteolytic chamber necessitating the complete unfolding of any substrate, whereas aggregated proteins are notoriously difficult to unfold. Though it has been widely hypothesized that protein aggregates require autophagy for degradation, Hjerpe et al. nevertheless suggest that, at least in the case of certain stress induced aggregates, the 26S proteasome is sufficient when UBQLN2 is around. These results also imply that UBQLN2-mediated aggregate clearance is coupled to disaggregase activity. The issue of whether human cells are capable of disaggregating large protein aggregates has also been controversial due to the fact that mammals do not possess an Hsp104 disaggregase homolog. On the other hand, it was recently demonstrated that the Hsp70-J-protein-Hsp110 chaperone network can provide potent protein disaggregation activity in mammalian cells (Nillegoda et al., 2015) . It will be valuable to examine in future studies whether the disaggregase activity supplied by Hsp70-Hsp110 is sufficiently robust to process most protein aggregates or whether the titration of monomers via degradation shifts the balance between partially soluble and aggregated misfolded proteins.
Finally, the authors utilize a mouse expressing glutamine-expanded Huntingtin as a model for aggregation, showing that UBQLN2 associates with aggregated polyQ Huntingtin. Mutating UBQLN2 in this background results in cognitive deficits and increased polyQ Huntingtin aggregation. Interestingly, it has been demonstrated that UBQLN2 only binds to particular types of protein aggregates: whereas UBQLN2 associates strongly with Huntingtin, it does not so with aggregates of ATXN3, Synuclein, or Tau (Zeng et al., 2015) . Moving forward, it will be essential to ascertain which specific features target an aggregate for UBQLN2-mediated degradation, and to examine the possibility that by interfering with aggregate clearance, UBQLN2 mutants exert a secondary effect on TDP43 and FUS in RNP granules, thus triggering the familiar ALS cellular pathology.
Immune complex-mediated diseases, such as systemic lupus erythematosus, commonly affect the kidney and determine disease prognosis. Stamatiades et al. now propose a kidney-specific mechanism for trans-endothelial transport of small immune complexes that activate strategically positioned tissue resident macrophages.
IgG antibodies are the key soluble effector molecules of the adaptive immune system. Upon IgG binding to antigen, immune complexes (IC) are formed, allowing the engagement of powerful effector mechanisms, including Fcg receptor (FcgR) ligation and complement activation. This process ensures effective antimicrobial activity. However, if circulating IC are not adequately cleared by macrophages of the reticuloendothelial system (RES) in the liver and spleen, they may become deposited in tissues and cause inflammation. The kidneys are particularly susceptible to developing inflammation in the presence of circulating IC, as observed in lupus nephritis and in post-streptococcal glomerulonephritis, but the mechanisms underlying this susceptibility have been unclear. In this issue of Cell, Stamatiades et al. demonstrate that in contrast to macrophages in other tissues, kidney macrophages readily take up circulating IC via FcgRs and initiate inflammation (Stamatiades et al., 2016) . They further show that this IC uptake is dependent on the unique anatomical position of kidney macrophages that are situated in close apposition to endothelial cells that transport circulating IC to them. IC binding to FcgR results in pro-inflammatory cytokine production and the subsequent recruitment of neutrophils and monocytes, propagating inflammation.
Tissue-resident macrophages populate the kidney during embryogenesis. They are derived from CSF1R-dependent yolk-sac precursors and self-renew throughout adult life (Schulz et al., 2012) . A variety of functions have been ascribed to kidney macrophages including clearance of cellular debris, neutrophils, and microbes, and initiation of repair, regeneration, and fibrosis following kidney injury (Rogers et al., 2014) . Several lines of evidence suggest that kidney macrophages are involved in IC-induced renal inflammation. For instance, MRL/lpr mice, which spontaneously develop autoantibodies and lupus nephritis, show significant disease amelioration if they are deficient in tissue-resident macrophages due to deletion of CSF1 or its receptor (Lenda et al., 2003) . Furthermore, in inducible models of lupus nephritis such as nephrotoxic serum transfer nephritis (NTN), macrophage depletion results in less severe renal pathology (Chalmers et al., 2015) , as does inhibition of FcgR signaling on myeloid cells (Sharp et al., 2013) . Although these studies have suggested that macrophage cytokine production may play a key role in the pathogenesis of IC-mediated inflammation, the mechanism by which macrophages access IC, the precise identity of the receptors mediating IC binding and the cellular consequences of IC exposure remain unknown.
Here, Stamatiades et al. (2016) find that, in contrast to dermal macrophages, epidermal Langerhans cells, alveolar macrophages and microglia, renal macrophages rapidly take up circulating IC within minutes of their administration. They confirm that circulating ICs reach the renal interstitium via trans-endothelial transport, where they encounter a population of yolk-sac derived F4/80
High ,
CX3CR1
High , CD11b int tissue-resident macrophages positioned along the abluminal side of the peritubular capillary endothelium (Figure 1 ). Intravital imaging shows that these macrophages extend long, highly motile filopodia along the capillary walls, facilitating surveillance of cargo transported into the interstitium by endothelial cells. The authors also find that IgG IC colocalize with renal macrophages in mice with lupus nephritis (the NZB/W model), suggesting that their findings are relevant to IC-mediated disease in vivo. Kidney macrophages ingest ICs via a FcgRIV-dependent, MyD88-and complement-independent mechanism, and this leads to the secretion of TNF-a, IL1b and CCL2, as well as the upregulation of MHC class II and costimulatory molecules. Circulating nucleic acid-containing IC lead to even greater macrophage activation, pointing to a synergy between FcgR engagement and TLR ligation in this context and providing a mechanistic explanation for the pathogenicity of autoantigen-containing IC in lupus nephritis.
This work raises several interesting questions. Macrophages are seeded in tissues during embryogenesis and their precise anatomical position relative to the vasculature differs in different organs (Figure 1 ). In the kidney, they lie between the endothelium and basement membrane and that position profoundly impacts their function. The mechanisms underlying this specific positioning and the signals that retain macrophages in this compartment and cause them to adopt such a distinctive morphology remain unclear. Given the close relationship between the endothelial cell and macrophage, some of these signals may well be endothelial cell-derived. The authors identify some of the cytokines produced by kidney macrophages in response to IC, but do not determine which of these are responsible for neutrophil and monocyte recruitment. This information would be of use in informing therapeutic strategies in ICmediated nephritis.
This study identifies FcgRIV as the key receptor required for the kidney macrophage response to circulating IC, suggesting that its human ortholog FcgRIIIA may play a similar role. Interestingly, genetic studies in systemic lupus erythematosus show that a single nucleotide polymorphism that encodes a receptor with reduced binding to IgG (FcgRIIIAF158), is associated with increased susceptibility to lupus and to lupus nephritis (Willcocks et al., 2009) . A possible explanation for this seeming discrepancy is that the impact of this low affinity FcgR on IC clearance by RES macrophages is more important than local effects on kidney macrophage activation. Nonetheless, it highlights the need to determine FcgRs expression and function in human kidney macrophages.
In summary, the finding of an endothelial cell-macrophage unit responsible for IC handling in the kidney solves the puzzle of why kidneys are susceptible to ICmediated diseases and highlights this pathway as a potential therapeutic target in these conditions.
